Pancytopenia as an early indicator for Stevens-Johnson syndrome complicated with hemophagocytic lymphohistiocytosis: a case report

BMC Pediatrics

Hai-Guo Yu¹  Xiao-Qing Qian¹  Zhi-Dan Fan¹ 

[1] Department of Rheumatology and Immunology, Nanjing Children’s Hospital Affiliated to Nanjing Medical University, No. 72 Guangzhou Road, Nanjing, Jiangsu Province 210008, China

关键词: Hemophagocytic lymphohistiocytosis (HLH);    Stevens-Johnson syndrome (SJS);    Early diagnosis;    Pancytopenia;   

Others  :  1139026
DOI  :  10.1186/1471-2431-14-38

 received in 2013-11-02, accepted in 2014-01-29,  发布年份 2014

【 摘 要 】

Background

Stevens-Johnson syndrome (SJS) is a severe skin and mucosal bullous disease. When complicated with Hemophagocytic lymphohistiocytosis (HLH), the condition is especially life-threatening.

Case presentation

Here we report the case of a 4-year-old boy suffering from SJS with extensive erythema multiforme and bulla. Despite active intervention and supportive care, the boy experienced increased skin lesions and a higher fever. Meanwhile, decreases in white blood cell count and hemoglobin were observed. Hyperferritinemia, increased soluble CD25 level, decreased NK cell activity and hemophagocytosis in the boy’s bone marrow confirmed the diagnosis of HLH. After high-dose intravenous immunoglobulin and methylprednisone pulse therapy, the boy was discharged in good condition.

Conclusion

Simultaneous occurrence of HLH and SJS is very uncommon and the condition is life-threatening. Pancytopenia can be a precocious indicator and enables to start a prompt diagnosis and treatment.

【 授权许可】

   
2014 Fan et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Mockenhaupt M: The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis. Expert Rev Clin Immunol 2011, 7:803-813.
• [2]Chen J, Wang B, Zeng Y, Xu H: High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases. Eur J Dermatol 2010, 20:743-747.
• [3]Janka GE: Familial and acquired hemophagocytic lymphohistiocytosis. Eur J Pediatr 2007, 166:95-109.
• [4]Henter JI, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G: HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007, 48:124-131.
• [5]Matsumoto Y, Naniwa D, Banno S, Sugiura Y: The efficacy of therapeutic plasmapheresis for the treatment of fatal hemophagocytic syndrome: two case reports. Ther Apher 1998, 2:300-304.
• [6]Park HS, Kim DY, Lee JH, Lee JH, Kim SD, Park YH, Lee JS, Kim BY, Jeon M, Kang YA, Lee YS, Seol M, Lee YJ, Lim YS, Jang S, Park CJ, Chi HS, Lee KH: Clinical features of adult patients with secondary hemophagocytic lymphohistiocytosis from causes other than lymphoma: an analysis of treatment outcome and prognostic factors. Ann Hematol 2012, 91:897-904.
• [7]Dhamankar M, Dessain SK: Hemophagocytic lymphohistiocytosis: a syndrome with diverse etiologies and treatment options. Clin Adv Hematol Oncol 2012, 10:262-265.
• [8]Larroche C: Hemophagocytic lymphohistiocytosis in adults: diagnosis and treatment. Joint Bone Spine 2012, 79:356-361.
• [9]Kardas F, Patiroglu T, Unal E, Chiang SC, Bryceson YT, Kendirci M: Hemophagocytic syndrome in a 4-month-old infant with biotinidase deficiency. Pediatr Blood Cancer 2012, 59:191-193.
• [10]Allen CE, Yu X, Kozinetz CA, McClain KL: Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2008, 50:1227-1235.
• [11]Goel S, Polski JM, Imran H: Sensitivity and specificity of bone marrow hemophagocytosis in hemophagocytic lymphohistiocytosis. Ann Clin Lab Sci 2012, 42:21-25.
• [12]Gupta A, Tyrrell P, Valani R, Benseler S, Weitzman S, Abdelhaleem M: The role of the initial bone marrow aspirate in the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2008, 51:402-404.
• [13]Demirkol D, Yildizdas D, Bayrakci B, Karapinar B, Kendirli T, Koroglu TF, Dursun O, Erkek N, Gedik H, Citak A, Kesici S, Karabocuoglu M, Carcillo JA, Turkish Secondary HLH/MAS Critical Care Study Group: Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment? Crit Care 2012, 16:R52. BioMed Central Full Text
• [14]Ma HH, Qian XQ, Yu HG, Zhang YY, Fan ZD: Clinical analysis on 23 cases of childhood macrophage activation syndrome. J of Southeast Univ (Med Sci Edition) 2012, 31:736-738.
• [15]Takahashi N, Chubachi A, Kume M, Hatano Y, Komatsuda A, Kawabata Y, Yanagiya N, Ichikawa Y, Miura AB, Miura I: A clinical analysis of 52 adult patients with hemophagocytic syndrome: the prognostic significance of the underlying diseases. Int J Hematol 2001, 74:209-213.
• [16]Lin CI, Yu HH, Lee JH, Wang LC, Lin YT, Yang YH, Chiang BL: Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases. Clin Rheumatol 2012, 31:1223-1230.